The influence of interferon-b (IFN-b) dosing time on antiviral activity was investigated in ICR male mice under light-dark cycle conditions (lights on at 07:00, off at 19:00) with food and water available ad libitum. There was a significant dosing time-dependent change in 2',5'-oligoadenylate synthetase (2',5'-OAS) activities, as an index of antiviral activity, in liver at 12 h after IFN-b (15 MIU /kg, i.v.) injection. IFN-b-induced 2',5'-OAS activity was more potent after the drug injection during the late dark phase. The higher antiviral effect of IFN-b was observed when the interferon-a /b receptor (IFNAR) expression in the liver increased, and the lower effect was observed when its expression decreased. IFN-b-induced fever was more serious after IFN-b injection from the late dark phase to the early light phase. A significant dosing time-dependent change was demonstrated for plasma IFN-b concentrations, which showed a higher level during the light phase and a lower level during the dark phase. The dosing time-dependent change of plasma IFN-b concentrations was not associated with that of the antiviral effect or fever induced by IFN-b. These results suggest that selecting the most suitable dosing time of IFN-b , associated with the 24-h rhythm of IFNAR expression in the liver, may be important to increase effectively the antiviral activity of the drug in experimental and clinical situations.
Relationship Between 24-Hour Rhythm in Antiviral Effect of Interferon-and Interferon-/ Receptor Expression in Mice
A 24-h rhythm has been demonstrated for a large number of physiological functions (1 -3) . The circadian oscillator in mammals is located in the suprachiasmatic nuclei (SCN) of the hypothalamus and plays a critical role in adapting endogenous physiological functions to cyclic environmental factors such as light, temperature and social communication. On the other hand, responses to a variety of drugs show 24-h rhythmicity (4 -6) . Use of a chronopharmacological strategy can improve the tumor response to treatment, and overall survival rates and reduce drug toxicities in humans (7, 8) . The mechanisms involved in the 24-h rhythm of drug susceptibility have been examined from the viewpoints of the sensitivity of living organisms to drugs and /or the pharmacokinetics of drugs.
Interferons (IFNs) are multifunctional cytokines that have not only antiproliferative and immunological effects but also potent antiviral effects (9) . IFNs have been widely used to treat patients with various types of cancer and hepatitis. On the other hand, adverse effects such as fever, headache and leukopenia are frequently observed in patients treated with IFNs (9) . In particular, fever is a frequent side effect in patients with IFN therapy. One approach to increase the efficiency of IFNs treatment is the administration of the drugs at the time that they are most effective and /or tolerated. Certainly, the fever (5, 10) or antiviral activity (10) induced by IFN-a is significantly affected by dosing time. However, the exact mechanisms have not been clarified yet.
IFN elicits biological activity through binding to specific receptors (11) . IFN-a and -b bind equally to interferon-a /b receptor (IFNAR) (12) . IFN-a and -b are the only effective antiviral agent that eliminates hepatitis virus from hepatocytes. However, only about half of the patients with hepatitis C virus (HCV) infection receiving IFN-a therapy are able to eliminate virus or normalize serum aminotrans-ferase (13, 14) . The response to IFN-a therapy is associated with the amount of serum HCV-RNA (15) and HCV genotype (16) . Furthermore, the expression of IFNAR in the liver is significantly related to the response to IFN therapy (17, 18) . Therefore, the inter or intraindividual variability of IFNAR level may be an important host factor influencing the response to IFN-a and -b.
Previous studies have demonstrated that the opiate receptor binding has a significant 24-h rhythm with a higher level during the dark phase (19) . The higher analgesic effectiveness of morphine is observed after drug injection during the dark phase in mice (20) . Also, the interindividual variability in response to a b-adrenoreceptor agonist or antagonist can be explained by the different b-adrenoceptor density on lymphocytes (21, 22) . Thus, the rhythmic change of receptor expression may mainly contribute to that of the effect induced by a receptor-mediated drug. However, little is known about the relationship between the 24-h rhythm of the pharmacological effect induced by receptor-mediated drugs and their receptor expression on target tissues.
This study was designed to clarify the influence of IFN-b dosing time on antiviral activity, 2',5'-oligoadenylate synthetase (2',5'-OAS) mRNA level, and activity in mice. The mechanism underlying the dosing time-dependent action of IFN-b was investigated from the viewpoints of the 24-h rhythm of IFNAR mRNA expression in liver and IFN-b pharmacokinetics. The relationship between the 24-h rhythm of the pharmacological effect induced by IFN-b and IFNAR expression was clarified.
MATERIALS AND METHODS

Animals
Male ICR mice (5-week-old) were purchased from the Charles River Japan, Inc. (Kanagawa). They were housed 8 -10 per cage under standardized light-dark cycle conditions (lights on at 07:00, off at 19:00) at 24 ± 1°C and 60 ± 10% humidity with food and water available ad libitum.
Drugs
The lyophilized powder of natural human IFN-b (Feron ® ) (Toray Industries, Inc., Tokyo) was dissolved in saline and intravenously (i.v.) injected (0.05 ml /kg of body weight).
Experimental design
To investigate the influence of IFN-b dosing time on 2',5'-OAS mRNA level and activity, groups of 7 -8 mice were injected with IFN-b (15 MIU /kg, i.v.) or saline at one of the following times of day: 09:00, 13:00, 17:00, 21:00, 01:00 or 05:00. The liver samples were quickly RNA extraction and RT-PCR Total RNA was extracted from liver or lymphocytes by using TRIZOL ® solution (BRL, Bethesda, MD, USA). The reverse transcription of RNA and cDNA amplification were performed with a one-step RT-PCR system (BRL). RT-PCR reactions were performed with 2',5'-OAS, COX-1, COX-2, IFNAR and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers. The following primers used: 5'-GCAAGCCTGATCCCAGAATCT-3' and 5'-TAGCCAC ACATCAGCCTCTTCA-3' for 2',5'-OAS (GenBank accession number: X04958), 5'-AGGAGATGGCTGCTGAG TTGG-3' and 5'-AATCTGACTTTCTGAGTTGCC-3' for COX-1 (GenBank accession number: M34141), 5'-ACAC ACTCTATCACTGGCACC-3' and 5'-TTCAGGGAGAA GCGTTTGC-3' for COX-2 (GenBank accession number: M82866), 5'-CATGGCTGGCTATATTGTTCC-3' and 5'-ATGGCTTGGGTTAAAGGTTTAC-3' for IFNAR (Gen-Bank accession number: U06237), 5'-GACCTCAACTAC ATGGTCTACA-3' and 5'-ACTCCACGACATACTCAGC AC-3' for GAPDH (GenBank accession number: M32599). The PCR product was electrophoresed through a 3% agarose gel including 0.2 m g/ml ethidium bromide, and the gel was photographed under UV light (302 nm). The band intensity was quantified using a NIH image analysis program and normalized against GAPDH.
Determination of 2',5'-OAS activity
Liver was perfused with phosphate-buffered saline (PBS) and then removed and placed into an ice-cold tube containing modified lysis buffer (10 mM HEPES-KOH / 50 mM KCl / 3 mM Mg(OAc)2 / 0.3 mM EDTA / 10% glycerol / 0.01% NaN 3 / 0.5% Triton-100 / 100 mM PMSF / 7 mM 2-mercaptoethanol, pH 7.5) (23) . The liver in the buffer was homogenized and centrifuged at 9,000´g for 20 min at 4°C. The supernatant was isolated and stored at -20°C. The protein concentrations in the liver homogenate sample were determined by Lowry's method. The liver 2',5'-OAS activities were determined by radioimmunoassay (2-5 A kit; Eiken, Tokyo). The 2',5'-OAS activities were expressed as 2',5'-oligoadenylate fmol per protein concentration.
Determination of rectal temperature
Rectal temperature was measured by a digital thermometer (Digital Thermometer TD-300; Shibaura Electronics, Tokyo). A lubricated thermocouple was inserted 1.5 cm into the rectum of mice. Rectal temperature was measured at least every 30 min to avoid hyperthermia caused by continuous handling stress (24) . Percent change of rectal temperature (%) from the basal level was calculated as follows:
Lymphocyte isolation
Spleen samples were homogenized to obtain single-cell suspensions including lymphocytes. Then the splenic lymphocytes were isolated by a density-gradient separation (Lympholyte-M ® ; Cosmo Bio, Tokyo). The isolated lymphocytes were suspended in Tris-buffered ammonium chloride to remove erythrocytes and were washed twice in PBS.
Specific IFN-a binding assay
The iodination of IFN-b reduces its biological potency by <30% (25) . Both IFN-a and -b cross-compete for the same receptor (12) . Therefore, recombinant human IFN-a (Pepro Tech EC, Ltd., London, UK) was used as ligand to the specific receptor of IFN-b. IFN-a was iodinated using a solid-phase lactoperoxidase kit (ICN Pharmaceuticals, Inc., Irvine, CA, USA). The splenic lymphocytes were isolated as described above and resuspended in ice-cold RPMI 1640 medium containing 0.25% bovine serum albumin, 0.1% sodium azide, 10 mg/ml protamine sulfate, 2.5 mM CaCl2, and the indicated concentrations of [ 125 I]-IFN-a . The binding assay was performed at 4°C for 2 h with a reaction mixture (a total volume 200 ml) containing various concentrations of [ 125 I]-IFN-a and 1´10 6 viable cells. After incubation, the reaction mixture was layered over 200 ml of heated-inactivated fetal bovine serum and centrifuged at 7,000´g for 1 min. The supernatant was removed. Thereafter, the tube tip containing bound ligand was amputated and the radioactivity was measured using a gammer counter (ARC-360; Aloka Co., Mitaka). Nonspecific binding was evaluated in the presence of at least 250-fold excess of unlabeled IFN-a. Specific binding was defined as nonspecific binding subtracted from the total binding. The data were plotted according to the method of Scatchard (26) . A molecular weight of 20,000 was assumed for the calculation of the receptor number per cell and the dissociation constant (Kd).
Determination of plasma IFN-b concentrations
Blood samples were collected by orbital sinus and plasma samples were obtained after centrifugation at 600´g for 3 min (Kubota Hematocrit KH-120A; Kubota, Tokyo) and stored at -20°C until assayed. Plasma IFN-b concentrations were determined by the enzyme-linkedimmunosorbent assay method (Human IFN-b ELISA kit, Toray Co.).
Pharmacokinetic analysis
Pharmacokinetic parameters were calculated by the nonlinear least-squares method, following the two-compartment model: total body clearance (CL), central volume of distribution (Vc), distribution rate constant from central to peripheral compartment (k12) and distribution rate constant from peripheral to central compartment (k21).
Statistical analyses
Analysis of variance (ANOVA) and Tukey's test were applied for the multiple comparison. Student's t-test was used for two independent groups. The 5% level of probability was considered to be significant.
RESULTS
Influence of IFN-b dosing time on liver 2',5'-OAS mRNA expression and activity
The 2',5'-OAS mRNA level in liver at 4 h after IFN-b (15 MIU /kg, i.v.) injection was significantly higher in mice treated with the drug at 01:00 or 05:00 (P<0.01, respectively, Fig. 1 ). However, the 2',5'-OAS mRNA in liver was not detected at 4 h after saline injection at any dosing times. On the other hand, the 2',5'-OAS activity in liver at 12 h after IFN-b injection at 05:00 or 17:00 was significantly higher when compared with that after saline injection at the corresponding dosing time (P<0.01, respectively, Fig. 2 ). Furthermore, the 2',5'-OAS activity in liver at 12 h after IFN-b injection at 05:00 was significantly higher than that after IFN-b injection at 17:00 (P<0.05). No dosing timedependent change was observed for 2',5'-OAS activity in liver at 12 h after saline injection.
Influence of IFN-b dosing time on rectal temperature
The rectal temperature showed a significant 24-h rhythm with a lower level during the light phase and a higher level during the dark phase (P<0.01, ANOVA, Fig. 3 ). The percent change of rectal temperature at 0.5 h after IFN-b (15 MIU /kg, i.v.) injection at 09:00, 13:00 or 05:00 was significantly higher than that after saline injection at the corresponding dosing time (P<0.01, respectively, Fig. 4 ). However, fever was not induced by IFN-b injection at 17:00, 21:00 or 01:00.
Influence of IFN-b dosing time on COX-1 or -2 mRNA expression in hypothalamus
The COX-2 mRNA level in the hypothalamus at 0.5 h after IFN-b injection at 09:00 or 21:00 was significantly higher than that after saline injection at the corresponding dosing time (09:00: P<0.01, 21:00: P<0.05, Fig. 5 ). Furthermore, it was significantly higher in mice injected with IFN-b at 09:00 than at 21:00 (P<0.05). However, the COX-1 mRNA was not induced by IFN-b injection at 09:00 or 21:00 ( Fig. 5 ).
24-Hour rhythm of IFNAR expression in liver and lymphocyte
The IFNAR mRNA level in liver and lymphocyte showed a significant 24-h rhythm (P<0.01, respectively, ANOVA, Fig. 6 ). The IFNAR mRNA level in liver was higher during the late dark phase and lower during the late light phase. The IFNAR mRNA level in lymphocytes was higher during the late dark phase and the early light phase, and lower during the late light phase and the early dark phase. Furthermore, the number of IFNAR per cell of lymphocytes, calculated from the intercept of the Scatchard plot on the abscissa, was significantly larger in cells prepared at 05:00 than at 17:00 (P<0.01, Table 1 ). The apparent Kd showed no significant difference between cells prepared at 05:00 and 17:00.
Influence of dosing time on IFN-b pharmacokinetics
The plasma IFN-b concentrations at 2.5 h after IFN-b (15 MIU /kg, i.v.) injection showed a significant 24-h rhythm with higher levels during the light phase and lower levels during the dark phase (P<0.01, ANOVA, Fig. 7 ). The influence of dosing time on the time course of plasma IFN-b concentrations after IFN-b injection is shown in Table 2 . The time course of plasma IFN-b concentrations after IFN-b injection decreased in a biexponential fashion. Plasma IFN-b concentrations at 1.5 and 3 h after IFN-b injection at 09:00 were significantly higher when compared with those after the drug injection at 21:00 (P<0.05, respectively). Table 3 shows the pharmacokinetic parameters after IFN-b injection. CL was significantly higher in mice injected with IFN-b at 21:00 than at 09:00 (P<0.05).
DISCUSSION
Antiviral efficacy of IFN is mediated through production of 2',5'-OAS activated by double-stranded RNA (27). 2',5'-OAS activates a latent ribonuclease, can cleave singlestranded RNA, and impairs replication of various virus (28, 29) . In this study, the 2',5'-OAS mRNA induction and its activity in liver after IFN-b injection were significantly more potent in mice injected with the drug during the late dark phase. This result was supported by a previous chronopharmacological finding of IFN-a (10) . IFN elicits antiviral activity by binding to the specific receptor on the cell surface (30) . In IFNAR-deficient cell lines, IFN-a and -b fail to induce 2',5'-OAS activity and protect against viral infection (31) . Furthermore, the level of IFNAR expression in liver is closely related to the efficacy of IFN-a therapy in patients with chronic hepatitis C (18, 32) . In the present study, the level of IFNAR mRNA in liver showed a significant 24-h rhythm with a higher level during the late dark phase and lower level during the late light phase. In addition, we examined the binding assay for IFNAR by using lymphocytes because the homogenization and processing of membranes for binding alter the binding kinetics of the receptor (33) . The number of IFNAR per cell was significantly larger in cells obtained at 05:00 than at 17:00. These results indicate that the rhythmic change of IFNAR mRNA level is associated with that of the number of IFNAR. Moreover, the 24-h rhythm of IFNAR mRNA level in the liver was consistent with the dosing timedependent change of 2',5'-OAS mRNA induction and its activation in liver by IFN-b. On the other hand, the plasma IFN-b concentrations at 2.5 h after IFN-b injection was higher during the light phase and lower during the dark phase. Namely, the rhythmicity of plasma IFN-b concentration was out of phase with the dosing time-dependent change of 2',5'-OAS activation induced by IFN-b . Therefore, the time-dependency in 2',5'-OAS activation of IFN-b seems to be due to not the rhythmicity of IFN-b pharmacokinetics but that of IFNAR expression. The change of rectal temperature at 0.5 h after IFN-b injection during the late dark phase and the early light phase was significantly higher than that after saline injection at the corresponding dosing time. However, no significant dosing time-dependence was observed for IFN-b concentrations at 0.5 h after IFN-b injection. IFN-a-induced fever Fig. 6 . The 24-h rhythm of IFNAR mRNA expression in liver and lymphocytes prepared at six different times. Relative mRNA level sets the mean peak value of each rhythm at 100%, respectively. Each value is the mean with S.E.M. of 5 -6 mice. A significant 24-h rhythm was demonstrated for liver and lymphocytes (P<0.01, respectively, ANOVA). is mediated by prostagrandin E2 (PGE2) production and /or an opioid receptor mechanism in the hypothalamus (34) . The dosing time-dependent difference of fever induced by IFN-a is caused by that of PGE2 production induced by the drug (10) . COX-2 plays a major role in the rapid production of PGE 2 and fever induced by IL-1b (35) . The hypothalamic COX-2 mRNA level, but not COX-1 mRNA level, was significantly higher in mice injected with IFN-b at 09:00 than at 21:00. Glucocorticoid inhibits the elevation of COX-2 mRNA as well as PGE2 formation induced by IL-1b (36, 37) . In rodents, plasma glucocorticoid hormone such as corticosterone shows 24-h rhythmicity with elevation during the late light phase and early dark phase. PGE 2 concentration in cerebrospinal fluid shows 24-h rhythm with higher level during the light phase, but with less magnitude in rats (38) . In this study, the serious fever induced by IFN-b was observed when plasma glucocorticoid level was lower (data not shown). Thus, the time-dependency in fever induced IFN-b may be due to the rhythmicity of plasma glucocorticoid level. A significant dosing time-dependent difference was also demonstrated for the pharmacokinetic parameter of IFN-b, which showed higher CL for injection at 21:00 than for injection at 09:00. The rhythmicity of CL seems to contribute to that of plasma IFN-b concentrations. The predominant pathway of IFN-b elimination is the liver (39) . IFN-a is internalized via receptor-mediated endocytosis and catabo-lized intracellulary by lysosomal proteinases in metabolic tissue (40) . The receptor-mediated saturable clearance of granulocyte colony-stimulating factor mainly contributes to total clearance at lower doses (41) . However, CL was significantly higher in mice injected with IFN-b at 21:00 than at 09:00, although the IFNAR mRNA level in liver was higher at 09:00 than at 21:00. Thus, the rhythmicity of IFNAR expression in liver may not contribute to the dosing time-dependent change of IFN-b pharmacokinetics.
In conclusion, we have shown here the dosing timedependency of the antiviral effect induced by IFN-b associated with that of IFNAR expression in the liver. The fever induced by IFN-b also showed a significant dosing timedependent change. Furthermore, the rhythmic change of IFN-b pharmacokinetics failed to elucidate that of pharmacological effects induced by IFN-b, although there was a significant dosing time-dependent difference in plasma IFN-b concentrations. Previous studies have shown that the interindividual variability in response of b-adrenoreceptor agonist or antagonist can be related to that in badrenoreceptor density on lymphocytes (21, 22) . Therefore, the choice of dosing time associated with the rhythmicity of IFNAR expression may help to achieve a rational chronopharmacological strategy for increasing the therapeutic effects of IFN-b. Also, the 24-h rhythm of IFNAR level on lymphocytes may be a reference marker for that of IFNAR level in the liver, since IFNAR mRNA levels in both Each value is the mean with S.E.M. of 5 -6 mice. Each value is the mean with S.E.M. of 5 -6 mice.
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lymphocytes and liver exhibit similar rhythmicities. However, it is still unclear which factors control the rhythmicity of IFNAR expression. To clarify the mechanisms may lead to the discovery of a more convenient rhythmic marker for IFNAR expression in each tissue. From this question, we might go on to a detailed examination of its mechanisms.
